MRONJ risk reduction pathway - 360 degree survey
Key Points Preventive dental screening reduces the incidence of MRONJ/BRONJ. A cross-service cross-healthcare boundary preventive pathway was developed. Alternative ways of delivering specialist led MRONJ/BRONJ preventive services can be successful with a robust clinical governance framework. Introd...
Gespeichert in:
| Veröffentlicht in: | British dental journal 2017-03, Vol.222 (5), p.386-390 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 390 |
|---|---|
| container_issue | 5 |
| container_start_page | 386 |
| container_title | British dental journal |
| container_volume | 222 |
| creator | Muthukrishnan, A. Al-Ismail, S. Bertelli, G. Browne, P. |
| description | Key Points
Preventive dental screening reduces the incidence of MRONJ/BRONJ.
A cross-service cross-healthcare boundary preventive pathway was developed.
Alternative ways of delivering specialist led MRONJ/BRONJ preventive services can be successful with a robust clinical governance framework.
Introduction
Bisphosphonates and denosumab reduce the risk of skeletal events in some malignancies (for example, breast, myeloma). These drugs carry a significant risk of a difficult-to-manage side effect of medication related osteonecrosis of the jaw (MRONJ). Preventive dental screening and treatment reduces the incidence of MRONJ. A managed clinical network (MCN) has been used to provide a MRONJ risk reduction pathway. A 360 degree survey was undertaken to assess the effectiveness of the pathway.
Aim
The aim of the 360 degree survey was to evaluate if this preventive pathway fulfilled its aims based on patient and stakeholder responses.
Method
A multidisciplinary, cross-service, cross-health board MRONJ preventive pathway has been developed. A 360 degree feedback survey of patients and other stakeholders was undertaken.
Results
Overall, this survey revealed high levels of satisfaction across patients, oncologists, community dental services, general dental services, and hospital managers.
Conclusion
Alternative ways of delivering MRONJ preventive pathways can be developed and assessed using iterative stakeholder feedback aided by a robust clinical governance framework. |
| doi_str_mv | 10.1038/sj.bdj.2017.225 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1881750740</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1876500671</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-181be4c9530875e1439329153d9b157788db2d2579c49b5285b94f4ee45811b33</originalsourceid><addsrcrecordid>eNqNkMtLAzEQh4MotlbP3mTBi5fdzuSxSY5SfKIWRM9hH2ndte3WZFfpf29Kq4ggeJrDfPObmY-QY4QEgamhr5O8rBMKKBNKxQ7pI5dpLJhku6QPADKGFKFHDryvAZBzSPdJjyqqUCjZJ3D_OH64jVzlXyNny65oq2YRLbP25SNbRXHEUohKO3XWRr5z73Z1SPYm2czbo20dkOfLi6fRdXw3vroZnd_FBdO6jVFhbnmhBQMlhUXONKMaBSt1jkJKpcqcllRIXXCdC6pErvmEW8uFQswZG5CzTe7SNW-d9a2ZV76ws1m2sE3nDSqFUoDk8A9UpgIglRjQ019o3XRuER5ZU-EuhqADNdxQhWu8d3Zilq6aZ25lEMzau_G1Cd7N2rsJ3sPEyTa3y-e2_Oa_RAcANoAPrcXUuh-L_8j8BPNHidE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1875773109</pqid></control><display><type>article</type><title>MRONJ risk reduction pathway - 360 degree survey</title><source>MEDLINE</source><source>SpringerNature Complete Journals</source><creator>Muthukrishnan, A. ; Al-Ismail, S. ; Bertelli, G. ; Browne, P.</creator><creatorcontrib>Muthukrishnan, A. ; Al-Ismail, S. ; Bertelli, G. ; Browne, P.</creatorcontrib><description>Key Points
Preventive dental screening reduces the incidence of MRONJ/BRONJ.
A cross-service cross-healthcare boundary preventive pathway was developed.
Alternative ways of delivering specialist led MRONJ/BRONJ preventive services can be successful with a robust clinical governance framework.
Introduction
Bisphosphonates and denosumab reduce the risk of skeletal events in some malignancies (for example, breast, myeloma). These drugs carry a significant risk of a difficult-to-manage side effect of medication related osteonecrosis of the jaw (MRONJ). Preventive dental screening and treatment reduces the incidence of MRONJ. A managed clinical network (MCN) has been used to provide a MRONJ risk reduction pathway. A 360 degree survey was undertaken to assess the effectiveness of the pathway.
Aim
The aim of the 360 degree survey was to evaluate if this preventive pathway fulfilled its aims based on patient and stakeholder responses.
Method
A multidisciplinary, cross-service, cross-health board MRONJ preventive pathway has been developed. A 360 degree feedback survey of patients and other stakeholders was undertaken.
Results
Overall, this survey revealed high levels of satisfaction across patients, oncologists, community dental services, general dental services, and hospital managers.
Conclusion
Alternative ways of delivering MRONJ preventive pathways can be developed and assessed using iterative stakeholder feedback aided by a robust clinical governance framework.</description><identifier>ISSN: 0007-0610</identifier><identifier>EISSN: 1476-5373</identifier><identifier>DOI: 10.1038/sj.bdj.2017.225</identifier><identifier>PMID: 28281587</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>692/308 ; 692/700/3032/3129/3136 ; 692/700/3032/3139 ; Bisphosphonate-Associated Osteonecrosis of the Jaw - epidemiology ; Bisphosphonate-Associated Osteonecrosis of the Jaw - prevention & control ; Bisphosphonates ; Communication ; Dental insurance ; Dentistry ; Dentists ; Drug therapy ; Feedback ; Health care access ; Health Care Surveys ; Hospitals ; Humans ; Incidence ; Medicine ; Necrosis ; Oncology ; Patients ; Risk Reduction Behavior ; Stakeholders ; Surgeons ; Surgery</subject><ispartof>British dental journal, 2017-03, Vol.222 (5), p.386-390</ispartof><rights>Springer Nature Limited 2017</rights><rights>Copyright Nature Publishing Group Mar 10, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-181be4c9530875e1439329153d9b157788db2d2579c49b5285b94f4ee45811b33</citedby><cites>FETCH-LOGICAL-c399t-181be4c9530875e1439329153d9b157788db2d2579c49b5285b94f4ee45811b33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/sj.bdj.2017.225$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/sj.bdj.2017.225$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28281587$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Muthukrishnan, A.</creatorcontrib><creatorcontrib>Al-Ismail, S.</creatorcontrib><creatorcontrib>Bertelli, G.</creatorcontrib><creatorcontrib>Browne, P.</creatorcontrib><title>MRONJ risk reduction pathway - 360 degree survey</title><title>British dental journal</title><addtitle>Br Dent J</addtitle><addtitle>Br Dent J</addtitle><description>Key Points
Preventive dental screening reduces the incidence of MRONJ/BRONJ.
A cross-service cross-healthcare boundary preventive pathway was developed.
Alternative ways of delivering specialist led MRONJ/BRONJ preventive services can be successful with a robust clinical governance framework.
Introduction
Bisphosphonates and denosumab reduce the risk of skeletal events in some malignancies (for example, breast, myeloma). These drugs carry a significant risk of a difficult-to-manage side effect of medication related osteonecrosis of the jaw (MRONJ). Preventive dental screening and treatment reduces the incidence of MRONJ. A managed clinical network (MCN) has been used to provide a MRONJ risk reduction pathway. A 360 degree survey was undertaken to assess the effectiveness of the pathway.
Aim
The aim of the 360 degree survey was to evaluate if this preventive pathway fulfilled its aims based on patient and stakeholder responses.
Method
A multidisciplinary, cross-service, cross-health board MRONJ preventive pathway has been developed. A 360 degree feedback survey of patients and other stakeholders was undertaken.
Results
Overall, this survey revealed high levels of satisfaction across patients, oncologists, community dental services, general dental services, and hospital managers.
Conclusion
Alternative ways of delivering MRONJ preventive pathways can be developed and assessed using iterative stakeholder feedback aided by a robust clinical governance framework.</description><subject>692/308</subject><subject>692/700/3032/3129/3136</subject><subject>692/700/3032/3139</subject><subject>Bisphosphonate-Associated Osteonecrosis of the Jaw - epidemiology</subject><subject>Bisphosphonate-Associated Osteonecrosis of the Jaw - prevention & control</subject><subject>Bisphosphonates</subject><subject>Communication</subject><subject>Dental insurance</subject><subject>Dentistry</subject><subject>Dentists</subject><subject>Drug therapy</subject><subject>Feedback</subject><subject>Health care access</subject><subject>Health Care Surveys</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Incidence</subject><subject>Medicine</subject><subject>Necrosis</subject><subject>Oncology</subject><subject>Patients</subject><subject>Risk Reduction Behavior</subject><subject>Stakeholders</subject><subject>Surgeons</subject><subject>Surgery</subject><issn>0007-0610</issn><issn>1476-5373</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqNkMtLAzEQh4MotlbP3mTBi5fdzuSxSY5SfKIWRM9hH2ndte3WZFfpf29Kq4ggeJrDfPObmY-QY4QEgamhr5O8rBMKKBNKxQ7pI5dpLJhku6QPADKGFKFHDryvAZBzSPdJjyqqUCjZJ3D_OH64jVzlXyNny65oq2YRLbP25SNbRXHEUohKO3XWRr5z73Z1SPYm2czbo20dkOfLi6fRdXw3vroZnd_FBdO6jVFhbnmhBQMlhUXONKMaBSt1jkJKpcqcllRIXXCdC6pErvmEW8uFQswZG5CzTe7SNW-d9a2ZV76ws1m2sE3nDSqFUoDk8A9UpgIglRjQ019o3XRuER5ZU-EuhqADNdxQhWu8d3Zilq6aZ25lEMzau_G1Cd7N2rsJ3sPEyTa3y-e2_Oa_RAcANoAPrcXUuh-L_8j8BPNHidE</recordid><startdate>20170310</startdate><enddate>20170310</enddate><creator>Muthukrishnan, A.</creator><creator>Al-Ismail, S.</creator><creator>Bertelli, G.</creator><creator>Browne, P.</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20170310</creationdate><title>MRONJ risk reduction pathway - 360 degree survey</title><author>Muthukrishnan, A. ; Al-Ismail, S. ; Bertelli, G. ; Browne, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-181be4c9530875e1439329153d9b157788db2d2579c49b5285b94f4ee45811b33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>692/308</topic><topic>692/700/3032/3129/3136</topic><topic>692/700/3032/3139</topic><topic>Bisphosphonate-Associated Osteonecrosis of the Jaw - epidemiology</topic><topic>Bisphosphonate-Associated Osteonecrosis of the Jaw - prevention & control</topic><topic>Bisphosphonates</topic><topic>Communication</topic><topic>Dental insurance</topic><topic>Dentistry</topic><topic>Dentists</topic><topic>Drug therapy</topic><topic>Feedback</topic><topic>Health care access</topic><topic>Health Care Surveys</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Incidence</topic><topic>Medicine</topic><topic>Necrosis</topic><topic>Oncology</topic><topic>Patients</topic><topic>Risk Reduction Behavior</topic><topic>Stakeholders</topic><topic>Surgeons</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Muthukrishnan, A.</creatorcontrib><creatorcontrib>Al-Ismail, S.</creatorcontrib><creatorcontrib>Bertelli, G.</creatorcontrib><creatorcontrib>Browne, P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>British dental journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Muthukrishnan, A.</au><au>Al-Ismail, S.</au><au>Bertelli, G.</au><au>Browne, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MRONJ risk reduction pathway - 360 degree survey</atitle><jtitle>British dental journal</jtitle><stitle>Br Dent J</stitle><addtitle>Br Dent J</addtitle><date>2017-03-10</date><risdate>2017</risdate><volume>222</volume><issue>5</issue><spage>386</spage><epage>390</epage><pages>386-390</pages><issn>0007-0610</issn><eissn>1476-5373</eissn><abstract>Key Points
Preventive dental screening reduces the incidence of MRONJ/BRONJ.
A cross-service cross-healthcare boundary preventive pathway was developed.
Alternative ways of delivering specialist led MRONJ/BRONJ preventive services can be successful with a robust clinical governance framework.
Introduction
Bisphosphonates and denosumab reduce the risk of skeletal events in some malignancies (for example, breast, myeloma). These drugs carry a significant risk of a difficult-to-manage side effect of medication related osteonecrosis of the jaw (MRONJ). Preventive dental screening and treatment reduces the incidence of MRONJ. A managed clinical network (MCN) has been used to provide a MRONJ risk reduction pathway. A 360 degree survey was undertaken to assess the effectiveness of the pathway.
Aim
The aim of the 360 degree survey was to evaluate if this preventive pathway fulfilled its aims based on patient and stakeholder responses.
Method
A multidisciplinary, cross-service, cross-health board MRONJ preventive pathway has been developed. A 360 degree feedback survey of patients and other stakeholders was undertaken.
Results
Overall, this survey revealed high levels of satisfaction across patients, oncologists, community dental services, general dental services, and hospital managers.
Conclusion
Alternative ways of delivering MRONJ preventive pathways can be developed and assessed using iterative stakeholder feedback aided by a robust clinical governance framework.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>28281587</pmid><doi>10.1038/sj.bdj.2017.225</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0007-0610 |
| ispartof | British dental journal, 2017-03, Vol.222 (5), p.386-390 |
| issn | 0007-0610 1476-5373 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1881750740 |
| source | MEDLINE; SpringerNature Complete Journals |
| subjects | 692/308 692/700/3032/3129/3136 692/700/3032/3139 Bisphosphonate-Associated Osteonecrosis of the Jaw - epidemiology Bisphosphonate-Associated Osteonecrosis of the Jaw - prevention & control Bisphosphonates Communication Dental insurance Dentistry Dentists Drug therapy Feedback Health care access Health Care Surveys Hospitals Humans Incidence Medicine Necrosis Oncology Patients Risk Reduction Behavior Stakeholders Surgeons Surgery |
| title | MRONJ risk reduction pathway - 360 degree survey |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T09%3A49%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MRONJ%20risk%20reduction%20pathway%20-%20360%20degree%20survey&rft.jtitle=British%20dental%20journal&rft.au=Muthukrishnan,%20A.&rft.date=2017-03-10&rft.volume=222&rft.issue=5&rft.spage=386&rft.epage=390&rft.pages=386-390&rft.issn=0007-0610&rft.eissn=1476-5373&rft_id=info:doi/10.1038/sj.bdj.2017.225&rft_dat=%3Cproquest_cross%3E1876500671%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1875773109&rft_id=info:pmid/28281587&rfr_iscdi=true |